NCT04965545 Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease
| NCT ID | NCT04965545 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Wilson Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2004-01-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2004-01-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators aimed to identify factors associated with symptoms and features of Wilson disease from a large cohort during long-term follow-up
Eligibility Criteria
Inclusion Criteria: * genetically diagnosed patients with wilson disease Exclusion Criteria: * Deny follow-up
Contact & Investigator
Zhi-Ying Wu
PRINCIPAL INVESTIGATOR
Second Affiliated Hospital, Zhejiang University School of Medicine
Frequently Asked Questions
Who can join the NCT04965545 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 65 Years, studying Wilson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04965545 currently recruiting?
Yes, NCT04965545 is actively recruiting participants. Contact the research team at dongyi720@zju.edu.cn for enrollment information.
Where is the NCT04965545 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT04965545 clinical trial?
NCT04965545 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The principal investigator is Zhi-Ying Wu at Second Affiliated Hospital, Zhejiang University School of Medicine. The trial plans to enroll 1,000 participants.